Naltrexone Transport by a Proton-Coupled Organic Cation Antiporter in hCMEC/D3 Cells, an in Vitro Human Blood–Brain Barrier Model

• Published in: Biological & pharmaceutical bulletin Vol. 45; no. 10; pp. 1585 - 1589
• Main Authors: Kitamura, Atsushi, Higuchi, Kei, Kurosawa, Toshiki, Okura, Takashi, Kubo, Yoshiyuki, Deguchi, Yoshiharu
• Format: Journal Article
• Language: English
• Published: Tokyo The Pharmaceutical Society of Japan 01.10.2022; Japan Science and Technology Agency
• Subjects: Acidification; Active transport; Ammonium; Ammonium chloride; Blood-brain barrier; Drug dependence; Endothelial cells; Hydrogen; membrane transport; Naltrexone; Narcotics; Opioid receptors (type mu); organic cation; Sodium azide
• ISSN: 0918-6158; 1347-5215; 1347-5215
• DOI: 10.1248/bpb.b22-00347

Naltrexone is a mu-opioid receptor antagonist used in the treatment of opioid and alcohol dependence. The blood–brain barrier (BBB) transport characteristics of naltrexone was investigated by means of hCMEC/D3 cells, a human immortalized brain capillary endothelial cell line. In hCMEC/D3 cells, naltrexone is taken up in a concentration-dependent manner. Furthermore, naltrexone uptake significantly decreased in the presence of H+/organic cation (OC) antiporter substrates, during the little alteration exhibited by substrates of well-identified OC transporters classified into SLC22A family. Although naltrexone uptake by hCMEC/D3 cells was partially affected by changes of ionic conditions, it was markedly decreased in the presence of the metabolic inhibitor sodium azide. Furthermore, when treated by ammonium chloride, naltrexone uptake by hCMEC/D3 cells was altered by intracellular acidification and alkalization, suggesting the involvement of oppositely directed proton gradient in naltrexone transport across the BBB. The results obtained in the present in vitro study suggest the active transport of naltrexone from blood to the brain across the BBB by the H+/OC antiporter.